Other languages Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
957 ^USD	+2.07%		+8.36%	+8.96%

05:40pm	Deutsche Bank Adjusts Price Target on Regeneron Pharmaceuticals to $870 From $880, Hold Rating Kept	MT
05:25pm	Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $1,180 From $1,126	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed Premarket Thursday	May. 02
Regeneron : BPA ajusté en repli de 4% au 1er trimestre	May. 02
Fed, Earnings Outlooks Lift Wall Street Pre-Bell; Asia Mixed, Europe Off	May. 02
Regeneron Pharmaceuticals' Q1 Non-GAAP Net Income, Revenue Decline	May. 02
Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of its shares.	May. 02
Stock Futures Gain Pre-Bell as Fed Leaves Key Rate Unchanged; Asia, Europe Churn	May. 02
Regeneron misses profit estimates on weaker Eylea and Dupixent sales	May. 02
Regeneron Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Borsa di Italia: qualcuno ci capisce qualcosa?	May. 02
Quelqu'un y comprend quelque chose ?	May. 02
IN DIRETTA DAI MERCATI: Amplifon, Aena, Generali, Nexi, Stellantis, Terna, Zignago Vetro, Novo Nordisk, Pandora, ING, eBay...	May. 02
En Direct des Marchés : Teleperformance, Worldline, Neoen, Imerys, Novo Nordisk, DoorDash, Shell...	May. 02
EN DIRECTO DESDE LOS MERCADOS: BBVA, Aena, Caixabank, Sabadell, Vidrala, ArcelorMittal, HSBC, Metrovacesa, Pandora, ING, eBay...	May. 02
Bolsa de Madrid: ¿Alguien lo entiende?	May. 02
ETF de la semana: El futuro de México parece dorado	May. 01
Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says	Apr. 26
Regeneron Pharmaceuticals Receives a Shareholder Proposal from John Chevedden	Apr. 25
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation Crispr-Based Gene Editing for Multiple Diseases	Apr. 25
Sanofi Q1 profit slips on generic competition, forex effects	Apr. 25
ETF de la semana: Diversificación en mercados fronterizos	Apr. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Other languages

Filters